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A Retrospective Study of Laboratory-Based Enteric Fever
Surveillance, Pakistan, 2012–2014
Farah Naz Qamar,1 Mohammad Tahir Yousafzai,1, Shazia Sultana,1 Attaullah Baig,1 Sadia Shakoor,1,2 Farzeen Hirani,1 Abdul Wassay,1
Sehrish Khushboo,1 Junaid Mehmood,1 Alexander Freeman,3 Kashmira Date,4 and Denise Garrett3
1Department of Paediatrics & Child Health, and 2Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan; 3Coalition Against Typhoid, Sabin
Vaccine Institute, Washington, DC; and 4Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia

Globally, typhoid and paratyphoid fever (2 similar illnesses
that constitute “enteric fever”) have been estimated to cause
190 000 deaths annually [1]. More than 90% of enteric fever–
related morbidity and mortality is reported from Asia, and
studies from some Asian countries have shown that incidence
of typhoid fever is highest among children aged <15 years [2, 3].
Because of a similar clinical presentation with other febrile illnesses, the utility of clinical diagnoses in enteric fever surveillance and disease burden estimation remains limited. Recent
estimates of blood culture–confirmed cases are not available to
calculate the incidence and disease severity of enteric fever in
Pakistan [4]. Additionally, the rise in antibiotic-resistant strains
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of Salmonella Typhi (S. Typhi) and Salmonella Paratyphi (S.
Paratyphi) has been associated with increased morbidity, mortality, and treatment costs [2, 3, 5, 6].
Existing studies have not provided reliable or recent population-based estimates to understand enteric fever disease burden and severity in South Asia. Data gathered from small-scale
studies, such as hospital case reviews, are often focus on disease
incidence in urban areas and are prone to spectrum bias focusing on severe cases, which has limited generalizability [3]. In
Karachi from 1999 to 2001, passive surveillance at 2 field sites
was used to estimate the annual serological incidence rate of
typhoid to be 710 per 100 000, whereas the annual incidence
rate for blood culture–confirmed cases was estimated at 170 per
100 000 [4]. The absence of credible estimates of the burden and
severity of enteric fever has limited understanding of the impact
of the disease and, therefore, hampers momentum for prevention and control efforts.
A substantial need remains to understand the changing
enteric fever antimicrobial resistance trends in South Asia.
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Introduction. The Surveillance for Enteric Fever in Asia Project (SEAP) is a multisite surveillance study designed to capture
morbidity and mortality burden of enteric fever (typhoid and paratyphoid) in Bangladesh, Nepal, and Pakistan. We aim to describe
enteric fever disease burden, severity of illness, and antimicrobial resistance trends in Pakistan.
Methods. In this retrospective, cross-sectional study, laboratory records of hospitalized patients who received a blood culture in
any of 3 Aga Khan University hospitals in Karachi and Hyderabad, Pakistan, from 2012 to 2014 were reviewed. A case was defined
as having a positive blood culture for Salmonella Typhi (S. Typhi) or Salmonella Paratyphi (S. Paratyphi). Antimicrobial sensitivity
patterns were characterized for all S. Typhi and S. Paratyphi isolates. Medical records were available for abstraction (demographics,
clinical features, complications) only among hospitalized cases.
Results. Of the 133 017 blood cultures completed during the study period, 2872 (2%) were positive—1979 (69%) for S. Typhi
and 893 (31%) for S. Paratyphi. Fluoroquinolone resistance was present in >90% of both the S. Typhi and the S. Paratyphi isolates;
almost none of the isolates were resistant to cephalosporins. Multidrug resistance (resistance to ampicillin, chloramphenicol, and
cotrimoxazole) was observed in 1035 (52%) S. Typhi isolates and 14 (2%) S. Paratyphi isolates. Among S. Typhi and S. Paratyphi
isolates, 666 (23%) were linked to hospitalized patients with medical records. Of the 537 hospitalized S. Typhi cases, 280 (52%) were
aged 5–15 years, 133 (25%) were aged 2–4 years, 114 (21%) were aged >15 years, and 10 (2%) were aged 0–1 years. Among the 129
hospitalized S. Paratyphi cases, 73 (57%) were aged >15 years, 41 (32%) were aged 5–15 years, 13 (10%) were aged 2–4 years, and
2 (2%) were aged 0–1 years. Significant differences in symptomology between S. Typhi and S. Paratyphi cases were observed for
nausea/vomiting, diarrhea, loss of appetite, and headache. Leukopenia, thrombocytopenia, and encephalopathy were the most commonly reported complications among enteric fever cases. No deaths were reported.
Conclusion. Evidence of high antimicrobial resistance levels and disease severity support the need for continued surveillance
and improved diagnostics for typhoid. Further prospective studies on vaccination as a tool for prevention of enteric fever in Pakistan
are needed to inform disease intervention strategies.
Keywords. enteric fever; surveillance; South Asia; typhoid; paratyphoid; Pakistan.

Wong and colleagues describe a phylogeographical analysis
that identified recent transfers and spread throughout Africa
and Asia of a multidrug-resistant H58 lineage of S. Typhi [7].
Without additional understanding of the mechanism of drug
resistance and development of strategies to control for resistance, treatment options for enteric fever are likely to become
obsolete [8]. As part of the Surveillance for Enteric Fever in
Asia Project (SEAP), this study aims to provide retrospective
evidence on enteric fever disease burden, illness severity, and
antimicrobial resistance trends in Pakistan.

Study Sites

Hospitals in Karachi and Hyderabad, Pakistan, were assessed
for study eligibility, which included having hospital laboratory blood culture capabilities and a systematic mechanism
for capturing, archiving, and retrieving medical record data.
Among the 8 hospitals assessed, 3 were eligible and participated in the study. Aga Khan University Hospital, located
in Karachi, is a 700-bed tertiary-care hospital with approximately 61 000 annual admissions in a catchment area of 23
million persons. Aga Khan Hospital for Women and Children,
located in Karachi, is a 48-bed secondary-care hospital with
approximately 2500 annual admissions in a catchment area of
approximately 75 000 persons. Aga Khan Hospital Hyderabad,
located in Hyderabad, is an 87-bed secondary-care hospital
with approximately 6500 annual admissions in a catchment
are of approximately half a million persons. Both Aga Khan
Hospital for Women and Children and Aga Khan Hospital
Hyderabad provide care for only women and children. All Aga
Khan University hospitals have centralized electronic medical
and laboratory record databases that use unique identification
numbers. The hospital labs have standardized blood culture
techniques that use an automated culture system (culture contamination rate: <2%).
Case Selection and Data Abstraction

The laboratory database was queried to identify all records
with a blood culture positive for S. Typhi or S. Paratyphi from
January 2012 to December 2014. For reporting of trends, all
positive blood isolates were included; multiple positive laboratory records obtained from a single patient were excluded.
Sensitivity testing at the lab follows Clinical and Laboratory
Standards Institute guidelines. Antimicrobial resistance data
patterns were abstracted, including those for ampicillin, chloramphenicol, cotrimoxazole, ciprofloxacin, cefixime, and ceftriaxone. Laboratory records were matched to medical records
from hospitalized patients using unique identification numbers.
Data abstracted from medical records included (1) demographics, (2) clinical presentation, (3) disease complications, (4) clinical investigations, and (5) diagnosis and patient outcomes.
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Data were collected on tablets with standardized forms and
transferred daily to a server. A 10% quality control of all study
records was conducted. The descriptive data analysis used SPSS
version 20.0 (Armonk, New York). Multidrug resistance was
defined as resistance to ampicillin, chloramphenicol, and cotrimoxazole [9]. Proportions of symptoms at the time of presentation were compared between patients with S. Typhi and patients
with S. Paratyphi using Pearson χ2 tests. P values less than .05
were considered statistically significant.
Ethical Considerations

The study was approved as nonresearch and exempted from a
full ethical review by the Ethical Review Committee of the Aga
Khan University, Karachi, Pakistan.
RESULTS

From among the 133 017 blood cultures available from lab
records at the study sites from 2012 to 2014, 2872 (2%) were
positive for enteric fever, including 1979 (69%) that were
positive for S. Typhi and 893 (31%) that were positive for S.
Paratyphi. The percentage of total culture-positive enteric fever
cases that were S. Typhi increased from 67% (n = 584) in 2012
to 68% (n = 654) in 2013 and 72% (n = 690) in 2014.
There was a decreasing trend of resistance to ampicillin, chloramphenicol, and cotrimaxazole from 2012 to 2014 (Table 1).
Resistance to ciprofloxacin was 93% in 2012, which slightly
decreased to 90% in 2014. Although resistance to ceftriaxone
was extremely low in our study population, there was a slight
increase from 0.1% in 2013 to 0.3% in 2014 (Table 1).
During the study period, elevated antimicrobial resistance
was identified in S. Typhi isolates against ampicillin (55%),
chloramphenicol (55%), and cotrimoxazole (56%); however,
minimal resistance to all 3 antibiotics (≤3%) was observed
in S. Paratyphi isolates (Figure 1, Table 1). Enteric fever isolates were almost entirely (>99%) sensitive to cephalosporins.
Although resistance to ciprofloxacin has remained relatively
stable at approximately 93% among S. Paratyphi isolates, a slight
decrease in resistance has been observed from 94% to 88% in
S. Typhi isolates from 2012 to 2014 (Figure 2). A decrease in
multidrug resistance was observed from 2012 to 2014 and was
driven by reduction in the resistance to ampicillin, chloramphenicol, and cotrimaxazole among S. Typhi isolates.
Among all enteric fever blood culture–positive cases, 2206
(77%) were outpatients and 666 (23%) were hospitalized. Most
(55%) hospitalized enteric fever cases received care in pediatric wards (Table 2). A provisional diagnosis of enteric fever was
provided to 86% of blood culture–confirmed enteric fever cases.
Among the 537 hospitalized cases of S. Typhi, 353 (66%) were
males. Similarly, males accounted for 58% of the 129 hospitalized S. Paratyphi cases. Comparable percentages were observed
for cases among infants aged ≤1 year for S. Typhi (1.9%) and
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MATERIAL AND METHODS

Data Management and Analysis

Table 1. Proportion of Salmonella Typhi and Salmonella Paratyphi Isolates Resistant to Various Antibiotics From Aga Khan University Hospitals, Karachi
and Hyderabad, Pakistan, by Year and Overall, 2012–2014
Ampicillin

Chloramphenicol

Ciprofloxacin

Ceftriaxone

Cotrimaxazole

MDR

No. (%)

No. (%)

No. (%)

No. (%)

No. (%)

No. (%)

Year
Salmonella Typhia
2012

375/584 (64)

384/585 (66)

549/586 (94)

0/585 (0)

385/586 (66)

365/584 (63)

2013

339/654 (52)

355/681 (52)

602/677 (89)

1/667 (0.1)

359/681 (53)

332/675 (49)

2014

344/689 (50)

350/706 (50)

626/707 (86)

3/706 (0.4)

356/708 (50)

338/702 (48)

Total

1058/1927 (55)

1089/1972 (55)

1777/1970 (90)

4/1958 (0.2)

1100/1975 (56)

1035/1961 (53)

Salmonella Paratyphi
8/294 (3)

7/302 (2)

281/303 (93)

0/301 (0)

7/302 (2)

4/301 (1)

2013

10/304 (3)

10/314 (3)

290/313 (93)

0/308 (0)

12/314 (4)

5/311 (2)

2014

6/273 (2)

8/274 (3)

256/276 (93)

0/275 (0)

8/274 (3)

5/274 (2)

Total

24/871 (3)

25/890 (3)

827/892 (93)

0/884 (0)

27/890 (3)

14/886 (2)

Abbreviation: MDR, multidrug resistance (resistant to ampicillin, chloramphenicol, and cotrimoxazole).
aA

total of 4 (0.2%) Salmonella Typhi isolates were resistant to cefixime, including 1 (<0.1%) in 2012, 1 (<0.1%) in 2013, and 2 (0.1%) in 2014.

S. Paratyphi (1.6%). However, S. Typhi case patients were generally younger, with 79% aged ≤15 years compared with 43% of S.
Paratyphi cases. Among enteric fever cases, the most commonly
reported symptoms were fever (97%), nausea/vomiting (40%),
and diarrhea (26%). Salmonella Typhi cases were more likely
to have reported nausea/vomiting, diarrhea, and anorexia compared with S. Paratyphi cases (P < .01). Salmonella Paratyphi
cases were more likely to have reported a headache (P < .05).
Leukopenia was the most common complication, affecting 11%
of S. Typhi cases and 16% of S. Paratyphi cases. Two cases of
intestinal perforation were observed, 1 for each S. Typhi and S.
Paratyphi. Encephalopathy was observed in 5 (0.9%) S. Typhi
cases and 1 S. Paratyphi (0.8%) case. No deaths were recorded,
and most cases of enteric fever were discharged, with <1% of
cases requiring transfer to another hospital.
DISCUSSION

cases reported in this study exceeds those reported in the same
hospitals from 2009 to 2011 [10]. The highest proportion of
typhoid cases were children aged 5–15 years, with more males
than females affected. Our results are consistent with studies
from Vietnam, where incidence of typhoid fever was highest
among children aged 5–9 years [11] but diverge from some of
the studies from India and Bangladesh that found the highest
incidence of typhoid among children <5 years old [11].
The findings in our retrospective study raise several concerns about antimicrobial resistance; however, none are as
alarming as the high prevalence of resistance to ciprofloxacin. Although no longer the standard of treatment for enteric
fever in South Asia, fluoroquinolones (ciprofloxacin) continue
to be preferentially prescribed in Pakistan. Without a rapid
diagnostic test to guide physicians in the diagnosis of enteric
fever, appropriate treatment of enteric fever will continue

This study provides critical information on burden, antimicrobial
resistance trends, and illness severity of enteric fever in Pakistan
from 2012 to 2014. The number of blood culture–confirmed
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Figure 1. Antimicrobial resistance patterns among Salmonella Typhi and
Salmonella Paratyphi isolates at Aga Khan University Hospitals, Karachi and
Hyderabad, Pakistan, 2012–2014. Abbreviation: MDR, multidrug resistance.
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Figure 2. Ciprofloxacin resistance among Salmonella Typhi and Salmonella
Paratyphi isolates at Aga Khan University Hospitals, by year, Karachi and Hyderabad,
Pakistan, 2012–2014.
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Table 2. Demographic and Clinical Characteristics of Patients Admitted
With Blood Culture–Confirmed Enteric Fever at Aga Khan University
Hospitals, Karachi and Hyderabad, Pakistan, 2012–2014
Typhoid
fever
Characteristics of patients

No.

No.

537

Paratyphoid
fever
%

No.

%

129

Sex
Male

353

65.7

75

58.1

Female

184

34.3

54

41.9

Age
10

1.9

2

1.6

2–4 y

133

24.8

13

10.1

5–15 y

280

52.1

41

31.8

>15 y

114

21.2

73

56.6

Location of patient admission
Medical

54

10.1

25

19.4

Pediatric

334

62.2

32

24.8

Surgical
Emergency
Other

12

2.2

12

9.3

128

23.8

54

41.9

9

1.7

6

4.7

Symptoms at the time of presentation
Fever

522

97.2

121

93.8

Nausea/vomiting*

228

42.5

37

28.7

Diarrhea*

153

28.5

22

17.1

Abdominal pain

109

20.3

34

26.4
17.1

Cough/difficulty breathing

97

18.1

22

102

19.0

10

7.8

General weakness

42

7.8

16

12.4

Headache**

32

6.0

14

10.9

Sore throat/flu

25

4.7

3

2.3

Seizures

19

3.5

3

2.3

9

1.7

2

1.6

82

15.3

26

20.2

Loss of appetite/low intake*

Constipation
Other
Provisional diagnosis

462

86.5

108

83.7

Acute febrile illness

Enteric fever

22

4.1

5

3.9

Pneumonia/RTI

17

3.2

5

3.9

6

1.1

0

0

30

5.6

11

8.5

UTI
Other
Complications
Leukopeniaa

61

11.4

20

15.5

Thrombocytopeniab

7

1.3

3

2.3

Encephalopathy

5

0.9

1

0.8

Hepatitis

3

0.6

1

0.8

Intestinal perforation

1

0.2

1

0.8

Hemodynamic shock

2

0.4

0

0

Renal impairment

1

0.2

0

0

Other

6

1.1

2

1.6

505

94.0

121

93.8

5

0.9

0

0

LAMA

18

3.4

5

3.9

Other

9

1.7

3

2.3

Outcome
Sent home
Referred to another hospital

*Statistically significant result (P < .01) in the comparison between typhoid and paratyphoid
patients.
**Statistically significant result (P < .05) in the comparison between typhoid and paratyphoid patients.
Abbreviations: LAMA, left against medical advice; RTI, respiratory tract infection; UTI, urinary tract infection.
aLeukopenia

was defined as reduced white blood cell count (<5000 per microliter of blood).
was defined as reduced platelet count (<50 000 per microliter of blood).

bThrombocytopenia
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0–1 y

to be difficult, resulting in treatment failures. The standard
treatments for enteric fever currently include cefixime and
ceftriaxone [12]. Although a minimal level of resistance to
cephalosporins was observed during the study period, antibiotic stewardship efforts will be imperative to retain the effectiveness of these disease treatment options. These concerns
have already been realized in a recently reported outbreak of
ceftriaxone-resistant S. Typhi in the Hyderabad city of Sindh,
Pakistan, in 2017. During the first 6 months of the outbreak,
>300 persons were identified by blood culture to be infected
with S. Typhi resistant to first-line antibiotics (ampicillin, chloroamphenicol, and cotimaxazole) and ceftriaxone but sensitive to meropenem and azithromycin [8]. First-line antibiotics
that make up the classification of multidrug resistance are no
longer the choice of treatment for enteric fever. Decreased use
of first-line drugs for enteric fever has likely contributed to the
continued reduction in multidrug resistance in Pakistan [10].
Our results are consistent with a recent systematic review
of enteric fever literature [13], which shows a high burden of
disease in South Asia and finds that complications other than
intestinal perforation are a frequent occurrence. A study conducted at a public-sector hospital in Pakistan reported 32 intestinal perforations over a 33-month period [14]. The prevalence
of intestinal perforation is likely underestimated in this study
because their inclusion criterion was a positive blood culture
for an enteric fever pathogen. There are several reasons why
patients with an intestinal perforation may not have a positive
blood culture, such as failure to obtain a blood culture or presurgical antibiotic therapy prior to blood collection. In addition, because the study hospitals in this analysis are private,
the cost of surgery may be prohibitive, resulting in intestinal
perforation cases self-diverting to other hospitals for care. This
study highlights that, although intestinal perforation is a hallmark complication of enteric fever, other complications, such as
encephalopathy, are relatively common.
This retrospective study has several limitations; these will in
part be addressed by a subsequent prospective SEAP study in
Pakistan. First, the study design does not fully allow for disease
burden to be estimated or incidence to be calculated. The disease burden in our study is underestimated due to absence of
community because this was a hospital-based survey [12], the
private hospital population is dissimilar to the community, only
patients who had a blood culture were included in the study,
and blood culture testing was used, which has a low sensitivity
(40%–60%). Phylogenetic analysis was not conducted on any of
the isolates reviewed in this study. Although the study provides
evidence on retrospective antibiotic resistance trends, analysis
to understand transmission patterns of S. Typhi with resistant
genetic traits in Pakistan was unavailable. In particular, understanding the impact of S. Typhi H58 [15–17] and other resistant
strains will be of future importance in maintaining effective
treatment. Finally, the full spectrum of disease severity could

not be captured because data were only abstracted from medical
records. Future studies will need to assess long-term follow-up
to capture all related disease complications and the associated
social and economic impacts.
Evidence of high antimicrobial resistance levels and disease severity support the need for continued surveillance and
improved diagnostics for typhoid. Further prospective studies on vaccination as a tool for prevention of enteric fever in
Pakistan are needed to inform disease intervention strategies.

the content of the manuscript have been disclosed.
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